Salesforce.com Inc (CRM)

CRM (NYSE:Computer Software & Services)
$54.00
neg -0.89
-1.62%
Today's Range: 53.86 - 55.20 | CRM Avg Daily Volume: 5,951,900
Last Update: 07/28/14 - 4:01 PM EDT
Volume: 4,017,123
YTD Performance: -0.54%
Open: $54.74
Previous Close: $54.89
52 Week Range: $42.11 - $67.00
Oustanding Shares: 614,000,000
Market Cap: 33,192,840,000
6-Month Chart
TheStreet Ratings Grade for CRM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 21 22 23 23
Moderate Buy 3 3 3 3
Hold 2 2 2 4
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
Mean Rec. 1.25 1.38 1.36 1.47
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -125.72
Price Earnings Comparisons:
CRM Sector Avg. S&P 500
-125.72 0.00 28.93
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.96% 27.00% 46.74%
GROWTH 12 Mo 3 Yr CAGR
Revenue 33.50 1.46 0.35
Net Income 0.00 -4.33 0.00
EPS 0.00 -4.00 0.00
Earnings for CRM:
EBITDA 0.33B
Revenue 4.07B
Average Earnings Estimates
Qtr (07/14) Qtr (10/14) FY (01/15) FY (01/16)
Average Estimate $-0.01 $-0.02 $-0.06 $0.08
Number of Analysts 9 9 10 9
High Estimate $0.00 $0.01 $0.01 $0.16
Low Estimate $-0.02 $-0.04 $-0.10 $-0.03
Prior Year $-0.09 $-0.12 $n.a. $-0.06
Growth Rate (Year over Year) 88.89% 87.04% n.a.% 237.37%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 8, 2014 | 1:25 PM EDT

It all starts with a one-day selloff.

By

Sham Gad

 | Jul 1, 2014 | 11:00 AM EDT

Today's perfect market conditions must end at some point.


By

Dan Fitzpatrick

 | Jul 1, 2014 | 8:30 AM EDT

Instead of playing the market you wish were there, trade the one that's actually in front of you.

By

Scott Redler

 | Jun 30, 2014 | 5:10 PM EDT

Salesforce.com has triggered our suggested entry.

By

Doug Kass

 | Jun 27, 2014 | 11:31 AM EDT
Speculative and disruptive companies often face skepticism and share price corrections in their early growth phase.
By

Timothy Collins

 | Jun 17, 2014 | 3:11 PM EDT

We've had a nice bounce in many smaller and momentum tech names.

By

Jim Cramer

 | Jun 16, 2014 | 3:38 PM EDT

It helps to understand how the market digests different fears.

By

Jim Cramer

 | Jun 9, 2014 | 6:50 AM EDT

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.

By

Jim Cramer

 | Jun 3, 2014 | 3:42 PM EDT

Energy, banks and food stocks are roaring, and momentum tech is still too risky.

By

Jim Cramer

 | Jun 2, 2014 | 3:15 PM EDT

There are simply too many players now.

I am still watching MON for a possible reversal against the time/price parameters. So far...
Market stages nice comeback from early losses to end basically flat. Gilead Sciences (GILD...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Cramer:  
DRI

Going to $47 without Otis...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.